Other substances

(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one on PubChem

Synonyms

2542

 

Structure image - (2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one

C1=CC(=C(C=C1[C@H]2[C@H](C(=O)C3=C(O2)C=C(C=C3)O)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein – Human ACE2 interface
Spike protein ACE2 Small molecule In silico 		in silico 2.46

Predicted to block the SARS-CoV-2 Spike protein-host ACE2 receptor interaction when combined with S-8510.

 Feb/08/2021

AI-suggested references

Link Publication date
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein - Human ACE2 interface.
Feb/08/2021
Export (.csv)